patients titrate up (0.25 0.51.01.72.4 mg weekly)
A 2025 study in JAMA Ophthalmology examined the association between semaglutide use and this condition
Reference: Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials by Sunil V Badve, Anika Bilal, Matthew M Y Lee, Naveed Sattar, Hertzel C Gerstein, Christian T Ruff, John J V McMurray, Peter Rossing, George Bakris, Kenneth W Mahaffey, Johannes F E Mann, Helen M Colhoun, Katherine R Tuttle, Richard E Pratley and Vlado Perkovic, 25 November 2024, The Lancet Diabetes & Endocrinology
Unlike traditional obesity treatments, which often focus on appetite suppression or calorie absorption, these drugs aim to modulate the body's underlying biological processes
They are
Make it sleek and smooth